Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Phenformin hydrochloride
Cat. No.:
OB0225LY-0396
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Phenformin hydrochloride is a macrocyclic hypoglycemic agent that was first used in the management of type 2 diabetes.
Synonym:
Phenformin HCl; Phenethylbiguanide hydrochloride; 834-28-6; N-Phenethylbiguanide; Fenformin; Phenformine; Phenethyldiguanide; Imidodicarbonimidic diamide, N-(2-phenylethyl)-; 1-(Diaminomethylidene)-2-(2-phenylethyl)guanidine
CAS No.:
834-28-6
Compound CID:
8249
Formula:
C10H16ClN5
Formula Weight:
241.72
Specification
Relative Density:
1.24 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Phenformin hydrochloride can be used in metabolic studies, especially playing an important role in studies of the effects on glucose metabolism and insulin sensitivity.
Library Information
Targets:
Potassium channel; AMPK
Pathways:
Autophagy; Chromatin/Epigenetic; Membrane transporter/Ion channel; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-6
Plate Location:
a11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 248.22 mM
Water Max Solubility:
44 mg/mL; 182 mM
Ethanol Max Solubility:
10 mg/mL; 41.4 mM
ALogP:
1.339
HBA_Count:
0
HBD_Count:
3
Rotatable Bond:
6
